Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Serotype 19A Is the Most Common Serotype Causing Invasive Pneumococcal Infections in Children
Jump to section
Related Articles
Cited By...
- Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001-2016
- Genome sequencing reveals that Streptococcus pneumoniae possesses a large and diverse repertoire of antimicrobial toxins
- Playing "Whack-a-Mole" With Pneumococcal Serotype Eradication
- Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of newborn mice to infection
- Draft Genome Sequence of an Atypical Strain of Streptococcus pneumoniae Serotype 19A Isolated from Cerebrospinal Fluid
- Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types
- Invasive Pneumococcal Disease After Implementation of 13-Valent Conjugate Vaccine
- Invasive Pneumococcal Disease in Infants Younger Than 90 Days Before and After Introduction of PCV7
- Changes in Streptococcus pneumoniae Serotype 19A Invasive Infections in Children from 1993 to 2011
- Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines
- Prediction of Pneumococcal Conjugate Vaccine Effectiveness against Invasive Pneumococcal Disease Using Opsonophagocytic Activity and Antibody Concentrations Determined by Enzyme-Linked Immunosorbent Assay with 22F Adsorption
- Invasive pneumococcal disease
- Inhibition of T Cells Provides Protection against Early Invasive Pneumococcal Disease